Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Pegylated L-asparaginase

EU orphan designation number: EU/3/08/569   
Active ingredient: Pegylated L-asparaginase
Indication: Treatment of acute lymphoblastic leukaemia
Sponsor: Sigma-Tau Rare Diseases, S.A.
Rua dos Ferreiros, 260, 9000-082 Funchal, Portugal

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
24/09/2008 Orphan designation EMEA/OD/032/08 (2008)5453 of 22/09/2008
1/10/2010 Transfer of orphan designation EMEA/OD/032/08/T/01 (2010)6806 of 28/09/2010
12/11/2012 Transfer of orphan designation EMEA/OD/032/08/T/02 (2012)8206 of 8/11/2012